REG - Belluscura PLC - Notice of AGM

BelluscuraAnnouncement

02/08/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240802:nRSB8752Ya&default-theme=true

RNS Number : 8752Y  Belluscura PLC  02 August 2024

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK
VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH
LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS
INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Belluscura plc

("Belluscura" or the "Company" or "Group")

 

 Notice of AGM

 

LONDON, U.K. AND PLANO, TX, U.S. (2 August 2024). Belluscura plc (AIM:BELL),
announces that the Notice of Annual General Meeting ("AGM"), to be held at
12.00 p.m on Tuesday 27 August 2024, is being posted to shareholders and will
shortly be available on the Company's website
at: https://investors.belluscura.com/investors/shareholder-information.

 

The Annual Report and Accounts for the year ended 31 December 2023 is
available on the Company's website
at: https://www.belluscura.com/financials/annual-and-interim-reports/

 

If you wish to submit a proxy vote for this meeting, please submit your vote
online at www.signalshares.com
(https://protect.checkpoint.com/v2/___http:/www.signalshares.com/___.bXQtcHJvZC1jcC1ldXcyLTE6bmV4dDE1OmM6bzozZjY1OWY4N2I0MTZlOGE5YTgwY2UwZjYyYjhiZGEzYzo2OjBlMTg6NTQyN2Y0ZDliNWE4MThiYTA3YzU1MDY2NGI5YmYzOTE4OTQyYWNlMjhhMzdmODU2M2NlMzM1ZjRkMTc3YTJjNDpwOkY6Tg)
. For your vote to be valid please ensure that it is received by no later
than 12.00 p.m. on 25 August 2024. Alternatively, should you wish to vote via
the CREST system, please see the instructions in the Notice of Meeting.

 

 

 

For further information please contact:

 Belluscura plc                             Tel: +44 (0)20 3128 8100
 Adam Reynolds, Chairman

Robert Rauker, Chief Executive Officer

Simon Neicheril, Chief Financial Officer

 SPARK Advisory Partners Limited            Tel: +44 (0)20 3368 3550

 Nominated Adviser
 Neil Baldwin / Jade Bayat

 Dowgate Capital Limited                    Tel: +44 (0)20 3903 7715

 Broker
 James Serjeant / Russell Cook

 MHP                                        Tel: +44 (0)20 3128 8100

 Financial PR & Investor Relations          email: Belluscura@mhpgroup.com
 Katie Hunt/Matthew Taylor

 

 

 

About Belluscura plc (www.belluscura.com
(https://protect.checkpoint.com/v2/___http:/www.belluscura.com___.bXQtcHJvZC1jcC1ldXcyLTE6bmV4dDE1OmM6bzozZjY1OWY4N2I0MTZlOGE5YTgwY2UwZjYyYjhiZGEzYzo2OjZkYWI6MWZjOGY5MTBlMjJlOGE2M2VmYzg0ZTQxYmVlZGI3YzMzZDE0OWRhMmVkNGZkODljMjc2ZWU5YWUzYTQ1Y2JiOTpwOkY6Tg)
)

Belluscura is a UK medical device company focused on developing oxygen
enrichment technology spanning broad industries and therapies. Our innovative
oxygen technologies are designed with a global purpose: to create improved
health and economic outcomes for the patients, healthcare providers and
insurance organisations.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAFZGGRKMDGDZM